# Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance

> **NCT06471088** · — · RECRUITING · sponsor: **Viatris Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Dovprela

## Interventions

- **DRUG:** Dovprela

## Key facts

- **NCT ID:** NCT06471088
- **Lead sponsor:** Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-23
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471088, "Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06471088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*